News
A federal district court in Delaware ruled that Viatris’ product, currently awaiting approval from the US Food and Drug Administration (FDA), does not infringe on Novo Nordisk’s patent for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results